These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7373025)

  • 21. Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice.
    Doenhoff MJ; Sabah AA; Fletcher C; Webbe G; Bain J
    Trans R Soc Trop Med Hyg; 1987; 81(6):947-51. PubMed ID: 3140436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental chemoprophylaxis against schistosomiasis. II. Stage I comparison of lucanthone, hycanthone, niridazole and oxamniquine (UK 4271).
    Jewsbury JM
    Ann Trop Med Parasitol; 1973 Dec; 67(4):431-8. PubMed ID: 4787715
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
    Botros S; Mahmoud S; Hassan S; Ibrahim A; Zidek Z; Masek K
    Arzneimittelforschung; 1996 Jan; 46(1):74-8. PubMed ID: 8821522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental chemotherapy of Schistosoma curassoni in mice.
    Vercruysse J; Southgate VR; Rollinson D; Hilderson H
    Parasitol Res; 1989; 75(7):559-62. PubMed ID: 2771923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of niridazole and hycanthone in schistosomiasis mansoni endemic areas.
    Katz N
    J Toxicol Environ Health; 1975 Nov; 1(2):203-9. PubMed ID: 1107578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of Schistosoma mansoni progeny to antischistosomal drugs.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1985; 27(4):186-9. PubMed ID: 3832339
    [No Abstract]   [Full Text] [Related]  

  • 27. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
    Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
    Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
    Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapeutic studies on experimental Schistosoma mansoni infection of Mastomys natalensis.
    Lämmler G; Petrányi G
    Bull World Health Organ; 1971; 44(6):739-50. PubMed ID: 5317444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schistosomiasis drug therapy and treatment considerations.
    Shekhar KC
    Drugs; 1991 Sep; 42(3):379-405. PubMed ID: 1720380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of schistosomiasis.
    Gilles HM
    J Antimicrob Chemother; 1981 Feb; 7(2):113-4. PubMed ID: 7216934
    [No Abstract]   [Full Text] [Related]  

  • 32. [Susceptibility to chemotherapeutic agents of Schistosoma mansoni isolates from patients treated with oxamniquine and praziquantel and not cured].
    Araújo N; de Souza CP; Passos LK; Simpson AJ; Dias Neto E; Pereira TR; Cerutti Júnior C; de Alencar FE; Dietze R; Katz N
    Rev Soc Bras Med Trop; 1996; 29(5):467-76. PubMed ID: 8966311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of known antischistosomal agents on early-developing forms of Schistosoma mansoni.
    Pereira LH; Pellegrino J; Mello RT
    J Parasitol; 1975 Apr; 61(2):249-52. PubMed ID: 805229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interventions for treating schistosomiasis mansoni.
    Saconato H; Atallah A
    Cochrane Database Syst Rev; 2000; (2):CD000528. PubMed ID: 10796552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of Schistosoma mansoni transmission by chemotherapy in St. Lucia. I. Results in man.
    Cook JA; Jordan P; Bartholomew RK
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):887-93. PubMed ID: 907051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

  • 37. Oxamniquine versus niridazole for treatment of uncomplicated Schistosoma mansoni infection.
    Kilpatrick ME; El Masry NA; Bassily S; Farid Z
    Am J Trop Med Hyg; 1982 Nov; 31(6):1164-7. PubMed ID: 7149102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimentally produced resistance of Schistosoma mansoni to hycanthone.
    Jansma WB; Rogers SH; Liu CL; Bueding E
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):926-36. PubMed ID: 907054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low.
    Stelma FF; Sall S; Daff B; Sow S; Niang M; Gryseels B
    J Infect Dis; 1997 Jul; 176(1):304-7. PubMed ID: 9207389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curative chemotherapy and resistance to reinfection in murine schistosomiasis.
    Andrade ZA; Azevedo de Brito P
    Am J Trop Med Hyg; 1982 Jan; 31(1):116-21. PubMed ID: 7058973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.